Eplerenone

An inhibitor of EGFR and VEGFR tyrosine kinases (IC₅₀s = 2, 6, 77, and 59 nM for EGFR, ErbB2, KDR, and FLT1, respectively) demonstrates antitumor activity and anti-angiogenic activity in numerous in vitro and in vivo models.

An inhibitor of EGFR and VEGFR tyrosine kinases (IC₅₀s = 2, 6, 77, and 59 nM for EGFR, ErbB2, KDR, and FLT1, respectively) demonstrates antitumor activity and anti-angiogenic activity in numerous in vitro and in vivo models.

An inhibitor of EGFR and VEGFR tyrosine kinases (IC₅₀s = 2, 6, 77, and 59 nM for EGFR, ErbB2, KDR, and FLT1, respectively) demonstrates antitumor activity and anti-angiogenic activity in numerous in vitro and in vivo models.

BUR E

A potassium-sparing diuretic that selectively blocks aldosterone activation of the mineralcorticoid receptor (IC₅₀ = 122 nM) indicated for the treatment of hypertension and heart failure.

A potassium-sparing diuretic that selectively blocks aldosterone activation of the mineralcorticoid receptor (IC₅₀ = 122 nM) indicated for the treatment of hypertension and heart failure.

A potassium-sparing diuretic that selectively blocks aldosterone activation of the mineralcorticoid receptor (IC₅₀ = 122 nM) indicated for the treatment of hypertension and heart failure.

A potassium-sparing diuretic that selectively blocks aldosterone activation of the mineralcorticoid receptor (IC₅₀ = 122 nM) indicated for the treatment of hypertension and heart failure.

EPR ASSY - INCLUDES EPR CABLE